Differences in gonadotropin-releasing hormone-induced calcium signaling between melatonin-sensitive and melatonin-insensitive neonatal rat gonadotrophs
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Antioxidants pharmacology MeSH
- Apamin pharmacology MeSH
- Calcium Channel Blockers pharmacology MeSH
- Potassium Channels drug effects MeSH
- Electrophysiology MeSH
- Type C Phospholipases antagonists & inhibitors MeSH
- Gonadotropin-Releasing Hormone pharmacology MeSH
- Pituitary Gland cytology drug effects metabolism MeSH
- Enzyme Inhibitors pharmacology MeSH
- Phosphodiesterase Inhibitors pharmacology MeSH
- Rats MeSH
- Melatonin pharmacology MeSH
- Membrane Potentials drug effects MeSH
- Patch-Clamp Techniques MeSH
- Nifedipine pharmacology MeSH
- Animals, Newborn physiology MeSH
- Ryanodine pharmacology MeSH
- Staurosporine pharmacology MeSH
- Calcium physiology MeSH
- Calcium Signaling drug effects MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Antioxidants MeSH
- Apamin MeSH
- Calcium Channel Blockers MeSH
- Potassium Channels MeSH
- Type C Phospholipases MeSH
- Gonadotropin-Releasing Hormone MeSH
- Enzyme Inhibitors MeSH
- Phosphodiesterase Inhibitors MeSH
- Melatonin MeSH
- Nifedipine MeSH
- Ryanodine MeSH
- Staurosporine MeSH
- Calcium MeSH
The sensitivity of GnRH-stimulated calcium signaling to melatonin, in a subpopulation of neonatal gonadotrophs, is supposed to be attributable to melatonin receptors. However, it is not yet known whether the intracellular pathway for GnRH action in melatonin-sensitive cells is the same as in melatonin-insensitive cells. By monitoring intracellular Ca2+ changes as an outward current carried through apamin-sensitive Ca2+-activated K+ channels, we compared GnRH-induced calcium responses in these two subpopulations of neonatal gonadotrophs. GnRH induced various oscillatory, as well as nonoscillatory, responses in both cell types that was not related to melatonin sensitivity. Melatonin-sensitive GnRH-induced responses could be clearly distinguished according to the pharmacological properties of their latency. The latency increased in zero extracellular Ca2+ or with the addition of nifedipine, staurosporine, and ryanodine. This effect was only rarely observed in melatonin-insensitive cells. This indicates that there are two pathways for initiation of GnRH-induced calcium signaling in neonatal gonadotrophs. The first pathway is mediated by inositol 1,4,5,-trisphosphate production, whereas the second involves extracellular calcium entry through voltage-dependent L-type Ca2+ channels, protein kinase C activation, and Ca2+ release from a ryanodine-sensitive store, which may coactivate Ca2+ release from an inositol 1,4,5,-trisphosphate-sensitive store. Only the second mechanism is accessible to inhibition by melatonin.
References provided by Crossref.org
Neurotransmitter receptors as signaling platforms in anterior pituitary cells
Ion Channels of Pituitary Gonadotrophs and Their Roles in Signaling and Secretion